FI900145L - Menetelmä farmaseuttisesti käyttökelpoisten 1,1-diokso-kefem-4-karbotiolihappojohdannaisten valmistamiseksi - Google Patents

Menetelmä farmaseuttisesti käyttökelpoisten 1,1-diokso-kefem-4-karbotiolihappojohdannaisten valmistamiseksi Download PDF

Info

Publication number
FI900145L
FI900145L FI900145A FI900145A FI900145L FI 900145 L FI900145 L FI 900145L FI 900145 A FI900145 A FI 900145A FI 900145 A FI900145 A FI 900145A FI 900145 L FI900145 L FI 900145L
Authority
FI
Finland
Prior art keywords
cephem
dioxo
preparation
acid derivatives
pharmaceutically useful
Prior art date
Application number
FI900145A
Other languages
English (en)
Swedish (sv)
Other versions
FI94642B (fi
FI900145A0 (fi
FI94642C (fi
Inventor
Marco Alpegiani
Pierluigi Bissolino
Ettore Perrone
Matteo Francesco Di
Piergiuseppe Orezzi
Giuseppe Cassinelli
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of FI900145A0 publication Critical patent/FI900145A0/fi
Publication of FI900145L publication Critical patent/FI900145L/fi
Publication of FI94642B publication Critical patent/FI94642B/fi
Application granted granted Critical
Publication of FI94642C publication Critical patent/FI94642C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI900145A 1988-05-13 1990-01-11 Menetelmä farmaseuttisesti käyttökelpoisten 1,1-diokso-kefem-4-karbotiolihappojohdannaisten valmistamiseksi FI94642C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB888811388A GB8811388D0 (en) 1988-05-13 1988-05-13 1,1-dioxo-cephem-4-carbothiolic acid derivatives
GB8811388 1988-05-13
EP8900505 1989-05-08
PCT/EP1989/000505 WO1989010926A1 (en) 1988-05-13 1989-05-08 1,1-dioxo-cephem-4-carbothiolic acid derivatives

Publications (4)

Publication Number Publication Date
FI900145A0 FI900145A0 (fi) 1990-01-11
FI900145L true FI900145L (fi) 1990-01-11
FI94642B FI94642B (fi) 1995-06-30
FI94642C FI94642C (fi) 1995-10-10

Family

ID=10636869

Family Applications (1)

Application Number Title Priority Date Filing Date
FI900145A FI94642C (fi) 1988-05-13 1990-01-11 Menetelmä farmaseuttisesti käyttökelpoisten 1,1-diokso-kefem-4-karbotiolihappojohdannaisten valmistamiseksi

Country Status (19)

Country Link
US (1) US5356888A (fi)
EP (1) EP0378604B1 (fi)
JP (1) JPH02504285A (fi)
KR (1) KR0147300B1 (fi)
AU (1) AU628821B2 (fi)
DE (1) DE68913498T2 (fi)
DK (1) DK10190A (fi)
ES (1) ES2016017A6 (fi)
FI (1) FI94642C (fi)
GB (1) GB8811388D0 (fi)
GR (1) GR1002249B (fi)
HU (1) HU208141B (fi)
IE (1) IE66309B1 (fi)
IL (1) IL90231A0 (fi)
NZ (1) NZ229023A (fi)
PT (1) PT90530B (fi)
RU (1) RU2091383C1 (fi)
WO (1) WO1989010926A1 (fi)
ZA (1) ZA893569B (fi)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE174919T1 (de) * 1989-10-06 1999-01-15 Synphar Lab Inc 2-spirocyclopropylcephalosporinderivate und verfahren zu ihrer herstellung
US5264429A (en) * 1989-10-06 1993-11-23 Synphar Laboratories, Inc. 2-spirocyclopropyl cephalosporin sulfone derivatives
US5258377A (en) * 1991-04-08 1993-11-02 Taiho Pharmaceutical Co., Ltd. 2-spirocyclopropyl 4-acylcephems
US5446037A (en) * 1991-12-05 1995-08-29 Synphar Laboratories, Inc. 2-[(substituted) methylene]cephalosporin sulfones as antiinflammatory, antidegenerative and antithrombin agents
US5439904A (en) * 1993-12-07 1995-08-08 Synphar Laboratories, Inc. 2-spiro(2'-spirocycloalkyl)cyclopropyl cephalosporin sulfones as antiinflammatory and antigenerative agents
US5629306A (en) 1994-12-09 1997-05-13 Research Corporation Technologies, Inc. 7-alkylidene cephalosporanic acid derivatives and methods of using the same
EP0859779A4 (en) * 1995-08-31 2000-04-12 Smithkline Beecham Corp INTERLEUKIN CONVERSION ENZYME AND APOPTOSIS
US5760027A (en) * 1996-12-06 1998-06-02 Research Corporation Technologies, Inc. Use of 7-alkylidene cephalosporins to inhibit elastase activity
US6407091B1 (en) * 1999-04-15 2002-06-18 Research Corporation Technologies, Inc. β-lactamase inhibiting compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1187323A (en) * 1967-06-26 1970-04-08 Fujisawa Pharmaceutical Co Sydnone and Sydnone Imine Derivatives of 7-Aminocephalosporanic Acids and Preparation thereof
US4623645A (en) * 1983-04-18 1986-11-18 Merck & Co., Inc. Substituted cephalosporin sulfoxides as anti-inflammatory and antidegenerative agents
US4547371A (en) * 1983-04-18 1985-10-15 Merck & Co., Inc. Substituted cephalosporin sulfones as anti-inflammatory and anti-degenerative agents
EP0124081A3 (en) * 1983-05-02 1986-11-26 Merck & Co. Inc. New substituted cephalosporin sulfones as antiinflammatory and antidegenerative agents, pharmaceutical compositions containing the same and processes for making them
US4699904A (en) * 1985-07-01 1987-10-13 Merck & Co., Inc. Tetrazolyl derivatives of β-lactams useful as elastase inhibitors
ATE133954T1 (de) * 1986-11-12 1996-02-15 Merck & Co Inc Substituierte cephalosporinsulfone als anti- entzündliche und anti-degenerative mittel
GB8808701D0 (en) * 1988-04-13 1988-05-18 Erba Carlo Spa Beta-lactam derivatives
US5258377A (en) * 1991-04-08 1993-11-02 Taiho Pharmaceutical Co., Ltd. 2-spirocyclopropyl 4-acylcephems

Also Published As

Publication number Publication date
DE68913498T2 (de) 1994-06-09
KR900701800A (ko) 1990-12-04
FI94642B (fi) 1995-06-30
GB8811388D0 (en) 1988-06-15
HUT54166A (en) 1991-01-28
ES2016017A6 (es) 1990-10-01
EP0378604A1 (en) 1990-07-25
GR890100309A (el) 1990-03-12
WO1989010926A1 (en) 1989-11-16
GR1002249B (en) 1996-04-23
HU208141B (en) 1993-08-30
NZ229023A (en) 1990-09-26
PT90530B (pt) 1994-11-30
AU3579289A (en) 1989-11-29
US5356888A (en) 1994-10-18
DK10190D0 (da) 1990-01-12
FI900145A0 (fi) 1990-01-11
ZA893569B (en) 1990-01-31
DE68913498D1 (en) 1994-04-07
KR0147300B1 (ko) 1998-08-17
EP0378604B1 (en) 1994-03-02
PT90530A (pt) 1989-11-30
AU628821B2 (en) 1992-09-24
JPH02504285A (ja) 1990-12-06
RU2091383C1 (ru) 1997-09-27
HU893631D0 (en) 1990-11-28
IL90231A0 (en) 1989-12-15
IE66309B1 (en) 1995-12-27
DK10190A (da) 1990-01-15
FI94642C (fi) 1995-10-10
IE891550L (en) 1989-11-13

Similar Documents

Publication Publication Date Title
FI872379A7 (fi) Menetelmä farmakologisesti vaikuttavien 1,5-diaryyli-3-(w-substituoitu-alempi-alkyyli)-pyratsolien valmistamiseksi
FI890282A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi
FI890508L (fi) Menetelmä farmaseuttisesti aktiivisten 3-indolipalorypälehappojohdannaisten valmistamiseksi
FI96861C (fi) Menetelmä terapeuttisesti aktiivisten substituoitujen indolyylipyrrolijohdannaisten valmistamiseksi
FI890072A7 (fi) Menetelmä farmaseuttisesti käyttökelpoisten isokinoliinijohdannaisten valmistamiseksi
FI903752A7 (fi) Menetelmä 1,2,3,4-tetrahydro-9-akridiiniamiinin johdannaisten valmistamiseksi
FI873350A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 1,4-dihydropyridiinijohdannaisten valmistamiseksi
FI906408L (fi) Menetelmä terapeuttisesti käyttökelpoisten 2-aminopyrimidiini-4-karboksamidijohdannaisten valmistamiseksi
PT87153A (pt) Process for the preparation of acid ribofuranuronic derivatives
FI871087A7 (fi) Menetelmä terapeuttisesti aktiivisten 1,2,3,4-tetrahydro-3-karbamoyyli-2-tiokso/okso-5-pyrimidiinikarboksyylihappojohdannaisten valmistamiseksi
FI893326A7 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 1,3-disubstituoitujen piperidiinijohdannaisten valmistamiseksi
FI881892A7 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten 1,2,5,6-tetrahydropyridiinijohdannaisten valmistamiseksi
FI880467A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 3,4-dihydro-2H-bentsopyraanien valmistamiseksi
FI93106C (fi) Menetelmä lääkeaineina käyttökelpoisten 2-iminobentsotiatsoliinijohdannaisten valmistamiseksi
FI894546A7 (fi) Menetelmä uusien 2'-halogeenimetylideeni-, 2'-etenylideeni- ja 2'-etynyyliadenosiinijohdannaisten valmistamiseksi
FI895983A0 (fi) Menetelmä lääkeaineina käyttökelpoisten 2-bentsotiatsoliinijohdannaisten valmistamiseksi
FI896075A7 (fi) Menetelmä 4,5,6,7-tetrahydrobentsimidatsolijohdosten valmistamiseksi
FI900145L (fi) Menetelmä farmaseuttisesti käyttökelpoisten 1,1-diokso-kefem-4-karbotiolihappojohdannaisten valmistamiseksi
FI892946A7 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 2,3,4,5-tetrahydro-1H-3-bentsoatsepiinijohdannaisten valmistamiseksi
FI893682L (fi) Menetelmä terapeuttisesti käyttökelpoisten 1,2,5-ditiatsosiinijohdannaisten valmistamiseksi
FI890477L (fi) Menetelmä terapeuttisesti käyttökelpoisen 2,5-diamino-6-fluoriheksaanihapon ja sen suolojen valmistamiseksi
FI93216C (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1,3-dioksaanialkeenihappojohdannaisten valmistamiseksi
FI893121L (fi) Menetelmä farmakologisesti aktiivisten 6,21-dimetyyli-19-norprogesteronijohdannaisten valmistamiseksi
FI910159A7 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten 9a-hydroksi-3-okso- 4,24(25)-stigmastadieeni-26-happojohdannaisten valmistamiseksi
FI891111A7 (fi) Menetelmä 1,4-dihydropyridiinijohdannaisten valmistamiseksi

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed
MM Patent lapsed

Owner name: FARMITALIA CARLO ERBA S.R.L